Thermo Fisher Scientific Inc (TMO) 152.14 $TMO Thermo

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Thermo Fisher Scientific Inc (TMO) 152.14 $TMO

Thermo Fisher Scientific Rises 1.07% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 22, 12:58PM CDT
Thermo Fisher Scientific (NYSE:TMO) traded in a range yesterday that spanned from a low of $149.05 to a high of $151.50. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $150.09 on volume of 406,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TMO: 152.14 (+2.29)

Thermo Fisher Grows Globally; Affimetrix Synergy on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:17AM CDT
On Jun 20, 2016, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).
MASI: 52.38 (+0.69), TMO: 152.14 (+2.29), CRY: 11.94 (+0.09), MLAB: 123.35 (+1.89)

SmarTrend Watching for Potential Rebound in Shares of Thermo Fisher Scientific After 1.74% Loss
Comtex SmarTrend(R) - Tue Jun 14, 1:15PM CDT
Thermo Fisher Scientific (NYSE:TMO) traded in a range yesterday that spanned from a low of $147.13 to a high of $149.82. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $150.44 on volume of 818,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TMO: 152.14 (+2.29)

Premarket Research Report Covering the Medical Laboratories & Research Industry
ACCESSWIRE - Thu Jun 09, 8:17AM CDT
LONDON, UK / ACCESSWIRE / June 9, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Medical Laboratories & Research industry. Companies recently under review include Thermo Fisher Scientific, Great Basin Scientific, PerkinElmer, and Organovo. Register with us now for your free membership and see our complete reports on these equities at:
GBSN: 1.74 (-0.05), TMO: 152.14 (+2.29), ONVO: 3.45 (+0.24), PKI: 54.23 (+0.99)

Thermo Fisher Scientific Strengthens Life Sciences Leadership with New Instruments Launched at ASMS 2016
BusinessWire - Mon Jun 06, 7:00AM CDT
Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, strengthened its industry-leading analytical instruments platform with innovative systems designed to help pharmaceutical and biologics producers more efficiently discover and develop candidate drugs. These new products will be on display at the 64th Annual American Society for Mass Spectrometry (ASMS) Conference, June 5-9 in Texas Ballroom D at the Grand Hyatt Hotel.
TMO: 152.14 (+2.29)

FEI COMPANY SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Wed Jun 01, 12:21PM CDT
Rigrodsky & Long, P.A.:
TMO: 152.14 (+2.29), FEIC: 106.00 (-0.02)

FEI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FEI Company
PR Newswire - Tue May 31, 2:09PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF" are investigating the proposed sale of FEI Company ("FEI" or the "Company" (NASDAQ: FEIC) to Thermo Fisher Scientific Inc. (NYSE: TMO). Under the terms of the proposed transaction, shareholders of FEI will receive only $107.50 in cash for each share of FEI that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
TMO: 152.14 (+2.29), FEIC: 106.00 (-0.02)

Milberg LLP Announces Investigation of Purchase of FEI Company by Thermo Fisher Scientific Inc.
PR Newswire - Tue May 31, 9:48AM CDT
Milberg LLP is investigating possible breaches of fiduciary duty and other violations of law in connection with the proposed acquisition of FEI Company (NASDAQ: FEIC) ("FEI" by Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher".
TMO: 152.14 (+2.29), FEIC: 106.00 (-0.02)

Thermo Fisher to Buy FEI, Boost Electron Microscopy Platform
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:58AM CDT
The FEI deal is expected to be accretive to Thermo Fisher's (TMO) adjusted EPS by 30 cents in the first full year after close.
BSX: 22.97 (+0.31), SRDX: 24.06 (+0.71), TMO: 152.14 (+2.29), BAX: 45.96 (+1.02), FEIC: 106.00 (-0.02)

Robbins Arroyo LLP: Acquisition of FEI Company (FEIC) by Thermo Fisher Scientific Inc. (TMO) May Not Be in Shareholders' Best Interests
BusinessWire - Fri May 27, 12:49PM CDT
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of FEI Company (NASDAQ: FEIC) by Thermo Fisher Scientific Inc. (NYSE: TMO). On May 27, 2016, the two companies announced the signing of a definitive merger agreement pursuant to which Thermo Fisher will acquire FEI Company. Under the terms of the agreement, FEI Company shareholders will receive $107.50 for each share of FEI Company common stock.
TMO: 152.14 (+2.29), FEIC: 106.00 (-0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of FEI Company to Thermo Fisher Scientific Inc. - FEIC
ACCESSWIRE - Fri May 27, 8:58AM CDT
NEW YORK, NY / ACCESSWIRE / May 27, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
TMO: 152.14 (+2.29), FEIC: 106.00 (-0.02)

FEI (FEIC) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of FEI Company; Are FEI Shareholders Getting a Fair Price?
PR Newswire - Fri May 27, 7:06AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of FEI Company (NASDAQ: FEIC) breached their fiduciary duties in connection with the proposed sale of the Company to Thermo Fisher Scientific Inc. (NYSE: TMO). FEI supplies scientific instruments and related services for nanoscale applications and solutions for industry and science.
TMO: 152.14 (+2.29), FEIC: 106.00 (-0.02)

Thermo Fisher Scientific to Acquire FEI Company
BusinessWire - Fri May 27, 6:00AM CDT
--Creates New Opportunities to Expand Presence in Attractive Materials Science Market
TMO: 152.14 (+2.29), FEIC: 106.00 (-0.02)

Thermo Fisher Scientific Set to Possibly Rebound After Yesterday's Selloff of 1.86%
Comtex SmarTrend(R) - Thu May 19, 2:15PM CDT
Thermo Fisher Scientific (NYSE:TMO) traded in a range yesterday that spanned from a low of $146.93 to a high of $149.56. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $147.70 on volume of 656,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TMO: 152.14 (+2.29)

Thermo Fisher Scientific Declares Quarterly Dividend
BusinessWire - Wed May 18, 3:30PM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on July 15, 2016, to shareholders of record as of June 15, 2016.
TMO: 152.14 (+2.29)

Thermo Fisher Posts Solid Q1; Affimetrix Integration Continues
Zacks Equity Research - Zacks Investment Research - Wed May 18, 6:40AM CDT
On May 18, 2016, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).
IRMD: 21.48 (+0.14), MASI: 52.38 (+0.69), TMO: 152.14 (+2.29), EW: 99.08 (+1.04)

Enzo Biochem's Life Sciences Unit Reaches $35 Million Patent Infringement Settlement in Delaware With Life Technologies Corporation
BusinessWire - Mon May 16, 3:07PM CDT
Enzo Biochem, Inc. (NYSE:ENZ) today announced that its subsidiary, Enzo Life Sciences, Inc., has reached and finalized a settlement with Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. (NYSE:TMO), involving payment of $35 million to Enzo in an action brought in Delaware Federal District Court by Enzo alleging infringement of its U.S. Patents Nos. 6,992,180 entitled Oligo- or Polynucleotides Comprising Phosphate Moiety Labeled Nucleotides and 7,064,197 entitled System, Array and Non-Porous Solid Support Comprising Fixed or Immobilized Nucleic Acids.
LIFE: 2.94 (+0.14), ENZ: 5.92 (+0.15), TMO: 152.14 (+2.29)

What Caused Illumina's Shares to Crash 19% In April
Todd Campbell, The Motley Fool - Motley Fool - Thu May 05, 7:20AM CDT
SOURCE: ILLUMINA INC. What:  After pre-announcing a revenue and profit shortfall, Illumina  saw its shares lose 19.1% of their value last month, according to data from S&P Global Market Intelligence . So what: The maker of instruments...
PACB: 8.60 (-0.19), TMO: 152.14 (+2.29), ILMN: 146.59 (+5.70)

Thermo Fisher Scientific to Host Analyst Meeting
BusinessWire - Wed May 04, 3:30PM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2016 Analyst Meeting on Wednesday, May 18, starting at 9:00 a.m. (EDT), at the Mandarin Oriental New York, 80 Columbus Circle at 60th Street, in New York City.
TMO: 152.14 (+2.29)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thunderly Bags Davey Awards for Creative Franchise Videos

Updated Category News Views 87

Big Wins from Humble Beginnings Ever notice how some small outfits have a knack for punching above their weight? Thunderly, a Dallas-based marketing agency, is a shining example of that. They've just snagged two Silver Awards at the 22nd Annual Davey Awards—and it’s stirring up talk across the sector. Winning a Davey isn’t child's play; it’s about small teams...

Continue Reading
Jacquie Lawson's Advent Calendar Delights Fans for 17th Year

Updated Category News Views 41

A Festive Tradition with a Twist The Jacquie Lawson Advent calendar is back for its 17th season, and it's no ho-hum affair. This time, the scene is set against the breathtaking backdrop of England's Lake District. If you've been yearning for a bit of that classic literary and natural charm, this is your ticket—minus the airfare. The calendar isn't just a countdown; it's...

Continue Reading
Jack Henry's Q1 2027 Deconversion Revenue Hits $17.9M

Updated Category News Views 49

Jack Henry Surprises with Strong Deconversion Revenue You're probably thinking, deconversion revenue—what on earth is that? Imagine you're in the financial tech business and one of your bigwig clients decides to merge or get gobbled up by another institution. They move shop, and voila, you've got some unexpected money flowing in due to that exit. That's deconversion...

Continue Reading
Courtney Clark to Keynote Stronger to Serve 2027

Updated Category News Views 75

Wipfli Sets the Stage for a Transformative Conference Wipfli, the heavyweight in advisory and accounting, is gathering the who's who of nonprofit and mission-driven leaders. But this time, they're putting a spotlight on resilience and adaptability. They're bringing in none other than Courtney Clark for the 2027 Stronger to Serve Conference slated for July 12-15 in...

Continue Reading
Bitcoin Mortgages: APX Ushers in New Canadian Era

Updated Category News Views 59

Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...

Continue Reading
xTool X1: Redefining Laser Fabrication for Makers

Updated Category News Views 140

The Next Generation of Laser Fabrication Whenever a new gizmo hits the market, it's usually just an upgrade in disguise—faster, shinier, a touch more wattage. Not this time. xTool shook things up by rolling out the X1, a laser platform that gets what small businesses and makers truly crave: versatility and long-lasting potential. This bad boy does more than engrave; it...

Continue Reading
American Lung Association's Bold $21M Research Investment

Updated Category News Views 25

Pumping Life into Lung Health Research The American Lung Association (ALA) just announced a jaw-dropping $21 million investment this year into lung health research. That's right, while some are counting beans, ALA is diving headfirst into serious health challenges plaguing millions of Americans. They've pumped hundreds of millions in the past decade, totaling $193...

Continue Reading
Cerebras Faces Durability Allegations: Investor Alert

Updated Category News Views 57

Cracks in Cerebras' Processor Promises? When you dance with high-stakes tech stocks, sometimes you end up stepping on a few toes. This seems to ring true as Cerebras Systems (CBRS) dances its way into hot water. Allegations from Culper Research suggest their fancy AI processors, which are supposed to be the poster children of reliability, might bow out early. Digging...

Continue Reading
Quanta Services Reports Record Q3 2026 Earnings

Updated Category News Views 79

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Continue Reading
Digital Science's Game-Changing Jenni AI Acquisition

Updated Category News Views 225

A Strategic Move in the Research Sector When you're dealing with tech giants and their endless race to corner niche markets, it's the big moves that really catch one's attention. The latest acquisition on the block is Digital Science picking up Jenni AI, a platform trusted by over 8 million students and researchers scattered across 189 countries. Now, that's a hefty user...

Continue Reading
/news?page=2">More News Articles